Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
Adrenergic Agonists: Indirect-Acting Agents01:25

Adrenergic Agonists: Indirect-Acting Agents

Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not necessarily...
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids01:24

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its effects by...
Drugs Acting on Autonomic Ganglia: Stimulants01:23

Drugs Acting on Autonomic Ganglia: Stimulants


Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Stimulants01:29

Stimulants

Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Groups of one.

Sexual abuse : a journal of research and treatment·1999
Same author

Organizing sexual abuse.

Sexual abuse : a journal of research and treatment·1999
Same author

The potter's box.

Sexual abuse : a journal of research and treatment·1999
Same author

Conventional and multiple-monitored electroconvulsive therapy. A comparison in major depressive episodes.

The Journal of nervous and mental disease·1986
Same author

Anxiolytic efficacy of alprazolam compared to diazepam and placebo.

The Journal of international medical research·1980
Same author

Enhancing the efficacy of lithium treatment by combined use with diuretics and low sodium diets: a preliminary report.

The Journal of clinical psychiatry·1979

Related Experiment Video

Updated: Jul 11, 2026

Event Related Potentials (ERPs) and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder (ADHD)
10:02

Event Related Potentials (ERPs) and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder (ADHD)

Published on: March 12, 2020

D-amphetamine and delinquency: hyperkinesis persisting?

B M Maletzky1

  • 1Department of Psychiatry and Neurology, US Lyster Army Hospital, Fort Rucker, Alabama, USA.

Diseases of the Nervous System
|December 1, 1974
PubMed
Summary

d-amphetamine shows significant clinical efficacy in treating adolescent delinquency when combined with psychotherapy. This stimulant medication may help adolescents with a history of childhood hyperactivity, suggesting a link between neurological dysfunction and antisocial behavior.

More Related Videos

Single Cell Measurement of Dopamine Release with Simultaneous Voltage-clamp and Amperometry
07:30

Single Cell Measurement of Dopamine Release with Simultaneous Voltage-clamp and Amperometry

Published on: November 21, 2012

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
09:16

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration

Published on: January 22, 2016

Related Experiment Videos

Last Updated: Jul 11, 2026

Event Related Potentials (ERPs) and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder (ADHD)
10:02

Event Related Potentials (ERPs) and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder (ADHD)

Published on: March 12, 2020

Single Cell Measurement of Dopamine Release with Simultaneous Voltage-clamp and Amperometry
07:30

Single Cell Measurement of Dopamine Release with Simultaneous Voltage-clamp and Amperometry

Published on: November 21, 2012

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
09:16

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration

Published on: January 22, 2016

Area of Science:

  • Neuroscience
  • Adolescent Psychiatry
  • Pharmacology

Background:

  • Childhood hyperactivity often persists into adolescence, manifesting as antisocial behavior.
  • Neurological dysfunction, including frontal lobe abnormalities, is observed in some juvenile delinquents with hyperactivity histories.
  • Pharmacological interventions, like stimulants, may offer insights into underlying neurological mechanisms in delinquency.

Purpose of the Study:

  • To evaluate the clinical efficacy of d-amphetamine versus placebo in adolescent delinquents.
  • To explore the relationship between childhood hyperactivity and response to d-amphetamine in adolescent delinquency.
  • To identify specific symptom clusters that benefit from d-amphetamine treatment in this population.

Main Methods:

  • Sequential analysis was employed to examine fourteen pairs of delinquent teenagers.
  • d-amphetamine was administered as an adjunct to ongoing psychotherapeutic regimens.
  • Comparison was made between d-amphetamine and placebo groups.

Main Results:

  • d-amphetamine demonstrated significant positive effects compared to placebo in reducing delinquent behavior.
  • No significant tolerance, withdrawal, or euphoria was observed with d-amphetamine use.
  • A strong correlation was found between a history of hyperactivity and positive clinical response to d-amphetamine.

Conclusions:

  • d-amphetamine is a potentially effective treatment for adolescent delinquency, particularly in individuals with a history of hyperactivity.
  • The findings suggest a continuous link between childhood hyperactivity and adolescent antisocial behavior, possibly mediated by neurological factors.
  • Further research is needed to understand the complexities of d-amphetamine use in adolescents and to refine treatment strategies.